Physician

Breton Adam Orel Yates, M.D.

According to 2025 Medicare claims, Breton Yates, M.D. (NPI: 1710242235) practices dermatology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is WOSETH DERMATOLOGY, P.C. (NPI: 1457470585; TIN: 87-0498345) and primary practice location at 84117-5209.

Yates' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 460 traditional Medicare patients, billed 3,261 HCPCS/CPT codes, and received $386,461 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 270 prescription claims across 189 beneficiaries totaling $7,125 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 49 records totaling $752. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,728 to $7,125. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$199K$398K2017 Medicare payment: $154,823 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $305,700 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $343,082 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $397,735 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $382,577 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $336,437 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $366,623 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $386,461 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20172291,246$154,823
20184203,034$305,700
20194953,644$343,082
20204743,520$397,735
20214743,504$382,577
20224683,253$336,437
20234343,042$366,623
20244603,261$386,461

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$7.1K$14K2015 Drug cost: $1,728 (USD; Tot_Drug_Cst)2016 Drug cost: $2,517 (USD; Tot_Drug_Cst)2017 Drug cost: $7,588 (USD; Tot_Drug_Cst)2018 Drug cost: $11,054 (USD; Tot_Drug_Cst)2019 Drug cost: $6,751 (USD; Tot_Drug_Cst)2020 Drug cost: $8,078 (USD; Tot_Drug_Cst)2021 Drug cost: $7,080 (USD; Tot_Drug_Cst)2022 Drug cost: $9,485 (USD; Tot_Drug_Cst)2023 Drug cost: $14,276 (USD; Tot_Drug_Cst)2024 Drug cost: $7,125 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151124$1,728
2016N/R20$2,517
201780129$7,588
2018170260$11,054
2019173257$6,751
2020197300$8,078
2021210304$7,080
2022174235$9,485
2023161229$14,276
2024189270$7,125

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks245348$469
11102Biopsy of related skin growth, first growth124151$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more295366$59
17000Destruction of precancer skin growth, 1 growth287346$37
17003Destruction of precancer skin growth, 2-14 growths2281,163$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil35983$2,784
Clobetasol PropionateClobetasol Propionate22619$926
CephalexinCephalexin91583$473
Gentamicin SulfateGentamicin Sulfate11262$410
Doxycycline MonohydrateDoxycycline Monohydrate26187$263

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.49$752Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Breton Adam Orel Yates, M.D.?

Tedicare shows public-source Medicare data for Breton Adam Orel Yates, M.D. (NPI 1710242235), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Breton Adam Orel Yates, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Breton Adam Orel Yates, M.D.?

Breton Adam Orel Yates, M.D. is linked to WOSETH DERMATOLOGY, P.C. (billing NPI 1457470585) in the available physician profile data.

Does Breton Adam Orel Yates, M.D. have Open Payments data?

Breton Adam Orel Yates, M.D. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.